Added to YB: 2025-11-18
Pitch date: 2025-11-15
CLPT [bullish]
ClearPoint Neuro, Inc.
-38.69%
current return
Author Info
Clinical Catalysts breaks down the science and strategy behind pharma market movers. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States.
Market Cap
$272.3M
Pitch Price
$15.30
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.10
P/E
-10.18
EV/Sales
7.70
Sector
Health Care Equipment and Supplies
Category
growth
Three Healthcare Names the Market is Sleeping On - ClearPoint Neuro, Inc.
CLPT: Med tech co building precision brain navigation systems for MRI/CT-guided procedures. 60+ biopharma partners, 9 in FDA expedited pathways. Q3 rev $8.9M (+9% YOY), 63% gross margin. 2025 guidance $36-38M, 2026 w/ IRRAS $54-60M. $445M mkt cap at $15.43. Positioned for intracranial gene/cell therapy growth.
Read full article (2 min)